[Vitamin C in a long-term trial is without effect on experimental carcinogenesis]

Area of Science:

• Oncology
• Gastroenterology
• Nutritional Science

Context:

• Chemically induced carcinogenesis models are crucial for understanding cancer development.
• N-Ethyl-N itro-N-nitrosoguanidine (ENNG) is a known carcinogen used to induce gastrointestinal tumors in rodent models.
• Ascorbic acid (Vitamin C) is studied for its potential chemopreventive properties.

Purpose:

• To investigate the long-term effects of high-dose ascorbic acid supplementation on the development of chemically induced small intestine cancer in rats.
• To determine if ascorbic acid influences tumor incidence, survival rates, or histological characteristics in this carcinogenesis model.

Summary:

• Rats treated with ENNG developed small intestine carcinoma, with an average survival of 238 days.
• Supplementation with high-dose ascorbic acid (3 g/100 g food) did not inhibit tumor development.
• Conversely, ascorbic acid significantly reduced average survival time to 207 days in ENNG-treated rats.
• Ascorbic acid alone did not affect survival or cause intestinal tissue changes.
• Histological tumor spread was not influenced by ascorbic acid administration.

Impact:

• This study suggests high-dose ascorbic acid may not be beneficial and could be detrimental in the context of ENNG-induced small intestine carcinogenesis.
• Findings highlight the importance of dose and context when evaluating the role of nutrients in cancer prevention.
• Results warrant further investigation into the mechanisms underlying ascorbic acid's effect on survival in this model.